Correlation with metastasis; Overexpressed in aromatase inhibitor resistant estrogen receptor-positive (ER+) breast cancer; overexpressed in metastatic relapse in node-positive breast cancer; upregulated in dormant breast cancer disseminated tumor cells. Here, ESR1 is linked to breast carcinoma.